Inhibikase Therapeutics shares owned by Sterling Capital Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Sterling Capital Management
from 13F filings
Historical chart of Sterling Capital Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Sterling Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $6.6k | 3.2k | 2.05 |
| 2025-09-30 | $6.2k | 3.8k | 1.62 |
| 2025-06-30 | $2.9k | 1.5k | 1.95 |
More positions owned by Sterling Capital Management
View all positions for Sterling Capital Management